Ergoteles LLC Edwards Lifesciences Corp Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $6.77 Million - $10 Million	78,280 New	78,280 $7.44 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $781,829 - $984,111	-7,668 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $815,645 - $1 Million	7,668 New	7,668 $993,000
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $660,270 - $787,564	-6,416 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $537,917 - $672,140	6,416 New	6,416 $665,000
Q1 2021 May 12, 2021	SELL	$78.68 - $90.67 $971,855 - $1.12 Million	-12,352 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$71.69 - $91.23 $885,514 - $1.13 Million	12,352 New	12,352 $1.13 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.